BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Aug 29, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

MoxDuo IR morphine/oxycodone regulatory update

QRxPharma completed submission of an NDA for MoxDuo IR morphine/oxycodone to treat moderate-to-severe acute pain. QRxPharma began the submission last month. The product is an immediate-release...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >